Research Article

Related GMR Articles

12/02/2013
Antigenotoxicity; Antimutagenicity; Cisplatin

Cisplatin is an effective antineoplastic drug. However, it provokes considerable collateral effects, including genotoxic and clastogenic activity. It has been reported that a diet rich in glutamine can help inhibit such collateral effects. We evaluated this activity in 40 Swiss mice, distributed into eight experimental groups: G1 - Control group (PBS 0.1 mL/10g body weight); G2 - ... more

R.J. Oliveira; E.S. Sassaki; A.C.D. Monreal; M.T.F.D. Monreal; J.R. Pesarini; M.O. Mauro; R. Matuo; A.F. Silva; N.N. Zobiole; J.M. Siqueira; L.R. Ribeiro; M.S. Mantovani
11/11/2013
Cisplatin; Histone deacetylase inhibitor; Malignant pleural mesothelioma; Panobinostat

New therapeutic approaches are still needed for effective malignant pleural mesothelioma treatment. The use of classical chemotherapy agents in combination with newly developed molecules may shed light on new therapeutic approaches. We aimed to determine the efficacy of panobinostat, alone and in combination with cisplatin, on cell survival and mRNA expression of FOXO3A, ... more

K.E. Gultekin; M.K. Yurdakonar; E. Yaman; U.S. Yuce; A. Yilmaz; E. Alp; A. Celik; S.M. Demiroz; H.I. Onen
06/18/2015
Cisplatin; Cisplatin-induced keratin 10; Multi-Drug Resistance; Ovarian cancer; Phosphatase and tensin homolog

Drug resistance is a major cause of treatment failure in ovarian cancer patients, and novel therapeutic strategies are urgently needed. Overexpression of phosphatase and tensin homolog (PTEN) has been shown to preserve the cisplatin-resistance of ovarian cancer cells, while cisplatin-induced keratin 10 (KRT10) overexpression mediates the resistance-reversing effect of PTEN. However, ... more

H. Wu; K. Wang; W. Liu; Q. Hao
05/25/2015
Cisplatin; Immune response; Lactobacillus; Lung cancer

The intestinal microflora affects inflammation and immunity, not only locally at the mucosal level but also systemically, raising the question of whether the microflora affects inflammatory processes that contribute to cancer and its therapy. Prebiotics have also been found to play an antitumor role that is not limited to the gut. We investigated the antitumor roles of the intestinal ... more

Q.F. Gui; H.F. Lu; C.X. Zhang; Z.R. Xu; Y.H. Yang
03/30/2015
Cisplatin; Inhibitory effect; Ovarian cancer; Signal transducer and activator of transcription 3 (STAT3)

The aim of the present study was to investigate the anti-ovarian cancer effect of the inhibitor of signal transducer and activator of transcription 3 (STAT3), WP1066. Western blot was used to detect the phosphorylation of STAT3 in ovarian cancer cell line SKOV3 and cisplatin-resistant ovarian cancer cell line SKOV3/DDP. MTT and colony-forming assays were performed to evaluate the ... more

Y.J. Tang; Z.L. Sun; W.G. Wu; J. Xing; Y.F. He; D.M. Xin; P. Han
03/12/2014
Antitumor; Nano-preparation; NGR; Paclitaxel; SWCNT

Single-walled carbon nanotubes (SWCNTs) have unique transmembrane abilities. The huge superficial area and abundance of π electrons confer SWCNTs perfect absorptive capability toward proteins, nucleates, and many drugs. These characteristics make SWCNTs a new and efficient drug carrier. The purpose of this study was to disperse SWCNTs in water and have paclitaxel absorbed onto them in ... more

X.D. Fu; Y.Y. Zhang; X.J. Wang; J.X. Shou; Z.Z. Zhang; L.J. Song
02/20/2015
Azithromycin; Intestinal microflora; Lactobacillus acidophilus; Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE)

The human intestine has a vast variety of microorganisms, and their balance is dependent on several factors. Antibiotics affect microfloral balance and allow naturally opportunistic organisms to multiply. Azithromycin is the most widely used macrolide antibiotic, active against a wide number of pathogens including Pseudomonas aeruginosa and Staphylococcus aureus. It is ... more

A. Shoaib; W. Dachang; Y. Xin